Porter Derrell Insider Trades

Insider Trading History

Track insider trading activity for Porter Derrell. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Passage Bio
Passage Bio PASG
Director
Holding Value $62.9k 10,539 shares
Last Trade
May 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$53.5k 10,539 shares
$5.08
$5.97
Acumen Pharmaceuticals
Acumen Pharmaceuticals ABOS
Director
Holding Value $44.7k 19,500 shares
Last Trade
Jun 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.9k 19,500 shares
$1.07
$2.29
Passage Bio
Passage Bio PASG
Director
Holding Value $1.21M 201,857 shares
Last Trade
May 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.45M 201,857 shares
$7.20
$5.97
Acumen Pharmaceuticals
Acumen Pharmaceuticals ABOS
Director
Holding Value $57.3k 25,000 shares
Last Trade
Jun 10, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$65.5k 25,000 shares
$2.62
$2.29
Passage Bio
Passage Bio PASG
Director
Holding Value $285k 47,693 shares
Last Trade
May 21, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.22M 47,693 shares
$25.60
$5.97
Acumen Pharmaceuticals
Acumen Pharmaceuticals ABOS
Director
Holding Value $57.3k 25,000 shares
Last Trade
Jun 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$130k 25,000 shares
$5.20
$2.29
Passage Bio
Passage Bio PASG
Director
Holding Value $143k 24,000 shares
Last Trade
May 25, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$480k 24,000 shares
$20.00
$5.97
Acumen Pharmaceuticals
Acumen Pharmaceuticals ABOS
Director
Holding Value $115k 50,000 shares
Last Trade
Jan 04, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$273k 50,000 shares
$5.46
$2.29
Passage Bio
Passage Bio PASG
Director
Holding Value $143k 24,000 shares
Last Trade
May 26, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$845k 24,000 shares
$35.20
$5.97
Passage Bio
Passage Bio PASG
Director
Holding Value $202k 33,836 shares
Last Trade
May 27, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.36M 33,836 shares
$276.60
$5.97
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Svp, Head Of Global Commercial
Holding Value $305k 31,688 shares
Last Trade
Mar 26, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.46M 10,000 shares
$945.75
$9.63
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Svp, Head Of Global Commercial
Holding Value $1.06M 109,666 shares
Last Trade
Feb 15, 2019 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.05M 4,000 shares
$1,011.25
$9.63
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Svp, Head Of Global Commercial
Holding Value $209k 21,688 shares
Last Trade
Feb 15, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.98M 5,909 shares
$1,011.25
$9.63
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Svp, Head Of Global Commercial
Holding Value $266k 27,597 shares
Last Trade
Feb 15, 2019 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.05M 4,000 shares
$1,011.25
$9.63
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Svp, Head Of Global Commercial
Holding Value $109k 11,284 shares
Last Trade
Feb 06, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.17M 1,216 shares
$961.75
$9.63
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Svp, Head Of Global Commercial
Holding Value $227k 23,597 shares
Last Trade
Feb 06, 2019 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.8M 12,313 shares
$961.75
$9.63
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Svp, Head Of Global Commercial
Holding Value $237k 24,625 shares
Last Trade
Feb 06, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$23.7M 24,625 shares
$961.75
$9.63
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Svp, Head Of Global Commercial
Holding Value $120k 12,500 shares
Last Trade
May 15, 2018 Sale (Open Market)Shares sold on the open market or in a private sale.
$18.7M 16,334 shares
$1,147.50
$9.63
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Svp, Head Of Global Commercial
Holding Value $278k 28,834 shares
Last Trade
May 15, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$18.7M 16,334 shares
$1,147.50
$9.63
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Svp, Head Of Global Commercial
Holding Value $1.09M 113,666 shares
Last Trade
May 15, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$18.7M 16,334 shares
$1,147.50
$9.63

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up